PDS Biotechnology (PDSB) Assets Average (2015 - 2026)

PDS Biotechnology (PDSB) has 11 years of Assets Average data on file, last reported at $32.6 million in Q4 2025.

• Quarterly Assets Average fell 33.34% year-over-year to $32.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $32.6 million (down 33.34% YoY) and the FY2025 annual result came in at $37.9 million, down 27.59% from the prior year.
• Assets Average fell to $32.6 million in Q4 2025, from $37.6 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $75.9 million in Q4 2022 to a low of $29.3 million in Q1 2021.
• A 5-year average of $57.1 million and a median of $59.5 million in 2022 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2021 — Assets Average jumped 173.46% — and 2025, when it slumped 33.44%.
• Tracing PDSB's Assets Average over 5 years: stood at $69.5 million in 2021, then gained by 9.32% to $75.9 million in 2022, then dropped by 23.25% to $58.3 million in 2023, then dropped by 16.1% to $48.9 million in 2024, then plunged by 33.34% to $32.6 million in 2025.
• The last three Assets Average figures came in at $32.6 million (Q4 2025), $37.6 million (Q3 2025), and $43.8 million (Q2 2025), per Business Quant data.